Hemorheological parameters are related to subclinical atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis patients

Atherosclerosis

Volumn 219, Issue 2, 2011, Pages 821-826

  Santos, Maria José ^a,b   Pedro, Luís Mendes ^c,d   Canhão, Helena ^a,e   Fernandes e Fernandes, José ^c,d   Canas da Silva, José ^b   Fonseca, João Eurico ^a,e   Saldanha, Carlota ^a  

^a INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^b HOSPITAL GARCIA DE ORTA   (Portugal)

^c Instituto Cardiovascular de Lisboa   (Portugal)

^d Lisbon Academic Medical Centre   (Portugal)

^e HOSPITAL DE SANTA MARIA   (Portugal)

Author keywords

Atherosclerosis; Hemorheology; Inflammation; Rheumatoid arthritis; Systemic lupus erythematosus

Indexed keywords

C REACTIVE PROTEIN; CORTICOSTEROID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; NITRIC OXIDE; TRIACYLGLYCEROL;

ADULT; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE; BLOOD RHEOLOGY; BLOOD VISCOSITY; BODY HEIGHT; BODY WEIGHT; CARDIOVASCULAR RISK; CAROTID INTIMA MEDIA THICKNESS; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; ERYTHROCYTE AGGREGATION; ERYTHROCYTE DEFORMABILITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FLOW KINETICS; HEMATOCRIT; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MENOPAUSE; METABOLIC SYNDROME X; NEGATIVE FEEDBACK; OBESITY; PLASMA VISCOSITY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SMOKING; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC LUPUS ERYTHEMATOSUS DISEASE ACTIVITY INDEX; THICKNESS; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WHOLE BLOOD VISCOSITY;

ADULT; ARTHRITIS, RHEUMATOID; ASYMPTOMATIC DISEASES; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BLOOD VISCOSITY; CASE-CONTROL STUDIES; ERYTHROCYTE AGGREGATION; ERYTHROCYTE DEFORMABILITY; FEMALE; HEMORHEOLOGY; HUMANS; INFLAMMATION MEDIATORS; LIPIDS; LOGISTIC MODELS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; NITRIC OXIDE; ODDS RATIO; PORTUGAL; RISK ASSESSMENT; RISK FACTORS;

EID: 82955194825     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.08.026     Document Type: Article

References (32)

1. Ward M.M. Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus. Arthritis and Rheumatism 1999, 42:338-346.
2. Meune C., Touze E., Trinquart L., Allanore Y. High risk of clinical cardiovascular events in rheumatoid arthritis: levels of associations of myocardial infarction and stroke through a systematic review and meta-analysis. Archives of Cardiovascular Diseases 2010, 103:253-261.
3. Roman M.J., Shanker B.A., Davis A., et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. The New England Journal of Medicine 2003, 349:2399-2406.
4. Del Rincon I., Williams K., Stern M.P., Freeman G.L., O'Leary D.H., Escalante A. Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects. Arthritis and Rheumatism 2003, 48:1833-1840.
5. Koenig W., Sund M., Filipiak B., Doring A., Lowel H., Ernst E. Plasma viscosity and the risk of coronary heart disease: results from the MONICA-Augsburg Cohort Study, 1984 to 1992. Arteriosclerosis, Thrombosis, and Vascular Biology 1998, 18:768-772.
6. Szapary L., Horvath B., Marton Z., et al. Hemorheological disturbances in patients with chronic cerebrovascular diseases. Clinical Hemorheology and Microcirculation 2004, 31:1-9.
7. Smith F.B., Lee A.J., Fowkes F.G., Price J.F., Rumley A., Lowe G.D. Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh Artery Study. Arteriosclerosis, Thrombosis, and Vascular Biology 1997, 17:3321-3325.
8. Lowe G.D., Lee A.J., Rumley A., Price J.F., Fowkes F.G. Blood viscosity and risk of cardiovascular events: the Edinburgh Artery Study. British Journal of Haematology 1997, 96:168-173.
9. Lowe G.D. Blood rheology in arterial disease. Clinical Science (London) 1986, 71:137-146.
10. Koenig W., Ernst E. The possible role of hemorheology in atherothrombogenesis. Atherosclerosis 1992, 94:93-107.
11. Baskurt O.K. In vivo correlates of altered blood rheology. Biorheology 2008, 45:629-638.
12. Ernst E., Hein A., Meurer M., Ruzicka T. Blood rheology in lupus erythematosus. Annals of the Rheumatic Diseases 1991, 50:710-712.
13. Rosenson R.S., Shott S., Katz R. Elevated blood viscosity in systemic lupus erythematosus. Seminars in Arthritis and Rheumatism 2001, 31:52-57.
14. Gudmundsson M., Oden A., Bjelle A. On whole blood viscosity measurements in healthy individuals and in rheumatoid arthritis patients. Biorheology 1994, 31:407-416.
15. Gladman D.D., Ibanez D., Urowitz M.B. Systemic lupus erythematosus disease activity index 2000. The Journal of Rheumatology 2002, 29:288-291.
16. Prevoo M.L., van't Hof M.A., Kuper H.H., van Leeuwen M.A., van de Putte L.B., van Riel P.L. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis and Rheumatism 1995, 38:44-48.
17. Steinvil A., Berliner S., Shapira I., et al. Time to rheology in acute myocardial infarction: inflammation and erythrocyte aggregation as a consequence and not necessarily as precursors of the disease. Clinical Research in Cardiology: Official Journal of the German Cardiac Society 2010, 99:651-656.
18. Levy B.I., Schiffrin E.L., Mourad J.-J., et al. Impaired tissue perfusion. Circulation 2008, 118:968-976.
19. Ong P.K., Namgung B., Johnson P.C., Kim S. Effect of erythrocyte aggregation and flow rate on cell-free layer formation in arterioles. American Journal of Physiology. Heart and Circulatory Physiology 2010, 298:H1870-H1878.
20. Lominadze D., Dean W.L., Tyagi S.C., Roberts A.M. Mechanisms of fibrinogen-induced microvascular dysfunction during cardiovascular disease. Acta Physiologica (Oxford) 2010, 198:1-13.
21. Recio-Mayoral A., Mason J.C., Kaski J.C., Rubens M.B., Harari O.A., Camici P.G. Chronic inflammation and coronary microvascular dysfunction in patients without risk factors for coronary artery disease. European Heart Journal 2009, 30:1837-1843.
22. Kensey K.R. The mechanistic relationships between hemorheological characteristics and cardiovascular disease. Current Medical Research and Opinion 2003, 19:587-596.
23. Vaya A., Murado J., Santaolaria M., et al. Haemorheological changes in patients with systemic lupus erythematosus do not seem to be related to thrombotic events. Clinical Hemorheology and Microcirculation 2008, 38:23-29.
24. Irace C., Scavelli F., Carallo C., Serra R., Gnasso A. Plasma and blood viscosity in metabolic syndrome. Nutrition, Metabolism, and Cardiovascular Diseases: NMCD 2009, 19:476-480.
25. Booth S., Chohan S., Curran J.C., Karrison T., Schmitz A., Utset T.O. Whole blood viscosity and arterial thrombotic events in patients with systemic lupus erythematosus. Arthritis and Rheumatism 2007, 57:845-850.
26. Lee A.J., Mowbray P.I., Lowe G.D., Rumley A., Fowkes F.G., Allan P.L. Blood viscosity and elevated carotid intima-media thickness in men and women: the Edinburgh Artery Study. Circulation 1998, 97:1467-1473.
27. Young C.N., Deo S.H., Padilla J., Laughlin M.H., Fadel P.J. Pro-atherogenic shear rate patterns in the femoral artery of healthy older adults. Atherosclerosis 2010, 211:390-392.
28. Cuhlmann S., Van der Heiden K., Saliba D., et al. Disturbed blood flow induces RelA expression via c-Jun N-terminal kinase 1: a novel mode of NF-kappaB regulation that promotes arterial inflammation. Circulation Research 2011, 108:950-959.
29. Wallberg-Jonsson S., Cvetkovic J.T., Sundqvist K.G., Lefvert A.K., Rantapaa-Dahlqvist S. Activation of the immune system and inflammatory activity in relation to markers of atherothrombotic disease and atherosclerosis in rheumatoid arthritis. The Journal of Rheumatology 2002, 29:875-882.
30. Gladwin M.T., Crawford J.H., Patel R.P. The biochemistry of nitric oxide, nitrite, and hemoglobin: role in blood flow regulation. Free Radical Biology & Medicine 2004, 36:707-717.
31. Woodward M., Rumley A., Tunstall-Pedoe H., Lowe G.D. Does sticky blood predict a sticky end? Associations of blood viscosity, haematocrit and fibrinogen with mortality in the West of Scotland. British Journal of Haematology 2003, 122:645-650.
32. Feher G., Koltai K., Papp E., et al. Aspirin resistance: possible roles of cardiovascular risk factors, previous disease history, concomitant medications and haemorrheological variables. Drugs and Aging 2006, 23:559-567.